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and lipoproteins is scarce.
OBJECTIVES This study sought to assess the longitudinal aging trajectory of lipids and lipoproteins for the life course
in adults and to determine whether CRF modiﬁes the age-associated trajectory of lipids and lipoproteins.
METHODS Data came from 11,418 men, 20 to 90 years of age, without known high cholesterol, high triglycerides, car-
diovascular disease, and cancer at baseline and during follow-up from the Aerobics Center Longitudinal Study. There were
43,821 observations spanning 2 to 25 health examinations (mean 3.5 examinations) between 1970 and 2006. CRF was
quantiﬁed by a maximal treadmill exercise test. Marginal models using generalized estimating equations were applied.
RESULTS Total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglycerides, and non–high-density li-
poprotein cholesterol (non–HDL-C) presented similar inverted U-shaped quadratic trajectories with aging: gradual in-
creases were noted until age mid-40s to early 50s, with subsequent declines (all p < 0.0001). Compared with men with
higher CRF, those with lower CRF developed abnormal values earlier in life: TC ($200 mg/dl), LDL-C ($130 mg/dl), non–
HDL-C ($160 mg/dl), and triglycerides/HDL-C ratio ($3.0). Notably, abnormal values for TC and LDL-C in men with low
CRF were observed around 15 years earlier than in those with high CRF. After adjusting for time-varying covariates, a
signiﬁcant interaction was found between age and CRF in each trajectory, indicating that CRF was more strongly asso-
ciated with the aging trajectories of lipids and lipoproteins in young to middle-age men than in older men.
CONCLUSIONS Our investigation reveals a differential trajectory of lipids and lipoproteins with aging according to CRF
in healthy men and suggests that promoting increased CRF levels may help delay the development of dyslipidemia.
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ABBR EV I A T I ON S
AND ACRONYMS
BMI = body mass index
CHD = coronary heart disease
CRF = cardiorespiratory ﬁtness
CVD = cardiovascular disease
HDL-C = high-density
lipoprotein cholesterol
LDL-C = low-density
lipoprotein cholesterol
TC = total cholesterol
TG = triglycerides
WC = waist circumference
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2092cholesterol (HDL-C) are important lipid risk
factors for CHD (4–7). Existing evidence also
suggests that elevated triglycerides (TG) are
an independent risk factor for CHD (8).
Age-related changes in lipid and lipopro-
tein concentrations are overall unfavorable.
For example, TC, LDL-C, and TG increase up
to middle age, then decrease (9–14), whereas
the change in HDL-C with aging is not
consistent (11–16). Most previous studies
had substantial limitations, including cross-
sectional study design (9,11), restricted age
range (14–16), relatively small sample size
(10,12,14,16), nonfasting samples (13), and alack of analysis assessing time-varying covariates
(12,15).SEE PAGE 2101Strong evidence suggests that physical activity is a
major modiﬁable lifestyle factor for preventing dys-
lipidemia (17–20). Meta-analyses and systematic re-
views support that aerobic physical activity reduces
LDL-C and non–HDL-C, with no consistent effect
observed on TG and HDL-C (17). However, an in-
creasing effect on HDL-C with speciﬁc amounts of
exercise and decreasing effects on TG has been re-
ported in healthy, middle-age men and in the over-
weight/obese population (20,21). Previous studies
have shown that improved cardiorespiratory ﬁtness
(CRF), an objective indicator of habitual physical
activity, resulted in a more favorable lipoprotein-
lipid proﬁle, with different effects across age groups
(18,19). However, there is little evidence on the effect
of CRF on age-related changes in lipids and lipopro-
teins. Because age-related changes in the lipid proﬁle
are mostly unfavorable, the aim of the current study
is to identify the age-related trajectory for lipids and
lipoproteins and, due to its important public health
and clinical implications, to explore factors that
might modify the trajectory.
More speciﬁcally, using data from the ACLS (Aer-
obics Center Longitudinal Study), we assessed the
longitudinal aging trajectory for TC, LDL-C, TG, HDL-C
and non–HDL-C and determined whether CRF modiﬁes
these trajectories in healthy men.
METHODS
STUDY POPULATION. The ACLS is a prospective
study of adults who received extensive preventive
medical examinations at the Cooper Clinic in Dallas,
Texas. The study participants are mainly non-
Hispanic whites (>95%) and college graduates from
middle to upper socioeconomic strata. Our analysesincluded male participants who received at least
2 medical examinations (2 to 25 visits; mean number
of visits ¼ 3.5) between 1970 and 2006. All study
participants had complete data on TC, HDL-C, and TG
at baseline, had normal resting and exercising elec-
trocardiograms, had a body mass index (BMI) $18.5
kg/m2, and were able to reach 85% of age-predicted
maximal heart rate during the treadmill tests at
each visit. We excluded participants who had a his-
tory of myocardial infarction, stroke, and cancer at
baseline and during the follow-up. In addition, par-
ticipants with self-reported high cholesterol or
high triglycerides during any visit were excluded to
remove potential treatment effects on lipid and li-
poprotein levels. Finally, a total of 11,418 individuals
with 43,821 observations were analyzed (Figure 1).
The study protocol was approved annually by the
Cooper Institute Institutional Review Board, and all
participants gave their informed consent for the
baseline examination and follow-up study.
ASSESSMENT OF CRF. CRF was measured using a
modiﬁed Balke protocol (22), and details of the mea-
surements are described elsewhere (23). Exercise
treadmill duration on this protocol is highly corre-
lated with measured peak oxygen uptake in men (24).
Treadmill time, expressed in metabolic equivalents,
corresponds to maximal aerobic power and is con-
sidered an objective laboratory measure of CRF. In a
previous study using ACLS data, CRF was demon-
strated to decline at a nonlinear rate with aging (23).
Thus, CRF was standardized for age, and the study
subjects were further categorized into low (lower
than 33.3th percentile), middle (those within 33.3th
to 66.7th percentile), and high (higher than 66.7th
percentile) CRF groups according to the distribution
of age-standardized CRF at baseline.
ASSESSMENT OF CLINICAL AND LIFE-STYLE
RELATED VARIABLES. Details of the clinical exami-
nation in ACLS are described elsewhere (23,25,26).
Examinations were conducted after an overnight
fast of at least 12 h. Serum TC, TG, HDL-C, and fasting
plasma glucose (FPG) were analyzed by automated
laboratory techniques in the Cooper Clinic in accor-
dance with quality control standards of the Centers
for Disease Control and Prevention Lipid Standardi-
zation Program. Blood pressure (BP) was measured
with mercury manometers after at least 5 min of quiet
sitting. BMI was calculated from measured weight
and height in accordance with standard procedures.
Waist circumference (WC) was measured at the level
of the umbilicus. Underwater weighing, sum of skin
fold-thickness, or both were used to estimate percent
body fat (% BF). When available, hydrostatically-
estimated % BF was chosen (26,27). A standardized
FIGURE 1 Participant Flow Diagram
20,695 participants
aged ≥20 years
9,277 excluded
11,418 included in the
final analytical dataset
Inclusion criteria
At least 2 examinations
Complete information on age, body mass
index, total cholesterol, triglycerides,
high-density lipoprotein cholesterol,
and exercise testing
•
•
Exclusion criteria
Abnormal electrocardiograms
Body mass index<18.5 kg/m2
Did not reach 85% of age-predicted
maximal heart rate
History of myocardial infarction
History of stroke
History of cancer
High cholesterol or high triglycerides
at baseline
History of known high cholesterol or
high triglycerides during follow-up
Outliers
Number
1,148
2,017
273
159
24
426
980
1,715
2,535
•
•
•
•
•
•
•
•
•
J A C C V O L . 6 5 , N O . 1 9 , 2 0 1 5 Park et al.
M A Y 1 9 , 2 0 1 5 : 2 0 9 1 – 1 0 0 Trajectories of Lipids and Lipoproteins With Aging
2093questionnaire was used to obtain information about
age, smoking, drinking alcohol, physical activity
habit, and past and family history of numerous health
indicators.
STATISTICAL ANALYSIS. Statistical analyses were
performed using SAS version 9.3 software (SAS
Institute Inc., Cary, North Carolina) and R software
(R Foundation for Statistical Computing, Vienna,
Austria). Data were expressed as mean  SD for
continuous variables and as proportions for categor-
ical variables. Marginal models were ﬁtted for the
longitudinal data, and the generalized estimating
equations approach was applied; this approach has
the main advantage of providing a robust inference of
the regression coefﬁcients, which is valid regardless
of whether or not the correlation structure is correctly
speciﬁed (28). An autoregressive moving average (1, 1)
model was chosen after careful comparison of popu-
lar correlation structures on the basis of log likelihood
ratio tests (29). Dependent variables for each marginal
model were TC, LDL-C, TG, HDL-C, and non–HDL-C.
Gamma distribution was applied for TG levels due to
its positive skewness. Using the EMPIRICAL option in
the PROC GLIMMIX statement, the classical sandwich
estimators were obtained as covariance estimators for
ﬁxed effects to ensure a consistent estimator.
In model 1, we evaluated the age-related longitudi-
nal change in TC, LDL-C, TG, HDL-C, and non–HDL-C.
Linear and quadratic models were both investigated.
In model 2, the inﬂuence of CRF was also examined.
The models were further adjusted for time-varying
covariates including WC, % BF, FPG, systolic and dia-
stolic BP, smoking status, drinking alcohol, and phys-
ical inactivity. Under the estimated correlationmatrix,
CRF was found to be highly correlated with WC and %
BF, respectively, which may indicate collinearity. This
may inﬂuence the association between CRF and the
age-related trajectories of lipids and lipoproteins. To
reduce possible collinearity issues, all marginal
modelswere ﬁttedwithWC and%BF as responses, and
with CRF as a predictor. Then, the residuals of these 2
variables with variations unexplained by CRF were
included in the multivariable models with other
covariates. In addition, all models were ﬁtted after
adjusting for the baseline examination time as a proxy
variable for the birth cohort.
We applied a log-likelihood ratio test to assess
whether the model improved the ﬁt. To compare
models, we also used the Bayesian information cri-
terion and Akaike information criterion to determine
the balance between obtaining a good ﬁt of the model
to the data and yielding precise parameter estimates.
All statistical tests were 2-sided, where p < 0.05 was
accepted as statistical signiﬁcance.For the graphical presentation of age-related tra-
jectories for lipids and lipoproteins, the crude overall
trajectories with aging under model 1 were examined.
To compare these trajectories among low-, middle-,
and high-CRF categories, WC representing abdominal
obesity was also considered with a constant WC re-
sidual (0.179, mean of the residual), along with age,
age squared, baseline examination date, CRF, and an
age–CRF interaction term. Cutoffs for abnormal lipids
and lipoproteins were set at: $200 mg/dl for TC; $130
mg/dl for LDL-C; $150 mg/dl for TG; $60 mg/dl
for HDL-C; $160 mg/dl for non–HDL-C; and $3.0 for
TG/HDL-C ratio (3,30,31).
SENSITIVITY ANALYSES. To eliminate the possible
inﬂuence of abnormal metabolic status or potential
behavioral changes on the trajectories, a sensitivity
analysis was performed among a subgroup of 5,554
participants, after excluding subjects with abnormal
lipid and lipoprotein proﬁles at baseline (those
having $240 mg/dl TC, $160 mg/dl LDL-C, $200
mg/dl TG, or <40 mg/dl HDL-C) or known diabetes
or hypertension at baseline and during follow-up
periods. To investigate the effects of diet on the
trajectories for lipids and lipoproteins, another sub-
group analysis was conducted among 2,361 partici-
pants who had records of low-fat or -cholesterol
dietary habits.
RESULTS
STUDY PARTICIPANTS. Baseline characteristics stra-
tiﬁed according to 3 CRF categories are presented
in Table 1. A higher CRF at baseline was inversely
associated with TC, LDL-C, TG, non–HDL-C, TG/HDL-C
TABLE 1 Descriptive Baseline Characteristics for the Subjects According to the Categories of CRF
Overall
(N ¼ 11,418)
Categories of CRF
p Value for
Linear Trend
Low
(n ¼ 5,130)
Middle
(n ¼ 3,625)
High
(n ¼ 2,663)
Age, yrs 43.8  9.0 44.2  8.7 43.9  9.0 43.0  9.5 <0.0001
Total cholesterol, mg/dl 202.6  36.1 207.6  36.8 201.6  34.9 194.4  34.6 <0.0001
LDL-C, mg/dl 132.3  32.5 136.2  32.8 132.0  31.7 125.1  31.6 <0.0001
TG, mg/dl 117.7  79.0 140.9  94.3 107.6  64.2 86.8  43.6 <0.0001
HDL-C, mg/dl 47.1  12.0 43.9  11.0 48.0  11.7 52.1  12.4 <0.0001
Non–HDL-C, mg/dl 155.5  37.1 163.7  37.5 153.6  35.5 142.3  34.4 <0.0001
TG/HDL-C ratio 2.88  3.28 3.67  4.02 2.53  2.83 1.84  1.28 <0.0001
TC/HDL-C ratio 4.57  1.43 5.00  1.51 4.43  1.32 3.91  1.07 <0.0001
LDL-C/HDL-C ratio 2.99  1.09 3.27  1.13 2.92  1.03 2.54  0.92 <0.0001
Maximal METs 12.4  2.3 10.5  1.2 12.8  0.8 15.4  1.6 <0.0001
Treadmill time duration, min 19.5  4.6 15.5  2.6 20.6  1.7 25.4  2.4 <0.0001
Height, cm 179.4  6.5 179.1  6.6 179.6  6.4 179.4  6.4 0.0028
Weight, kg 83.4  12.2 87.6  13.6 82.0  10.2 77.4  8.5 <0.0001
BMI, kg/m2 25.9  3.3 27.3  3.7 25.4  2.6 24.0  2.0 <0.0001
Waist circumference, cm 92.3  9.7 96.9  10.0 90.8  7.8 85.7  6.6 <0.0001
Percent body fat 20.3  6.1 23.4  5.6 19.5  5.0 15.5  5.0 <0.0001
Fasting plasma glucose, mg/dl 98.5  13.3 100.1  15.6 97.7  12.0 96.6  9.2 <0.0001
Systolic blood pressure, mm Hg 119.5  12.6 120.3  12.6 118.8  12.3 119.1  12.7 <0.0001
Diastolic blood pressure, mm Hg 80.0  9.1 81.5  9.4 79.2  8.9 78.2  8.4 <0.0001
Diabetes 314 (2.8) 209 (4.1) 69 (1.9) 36 (1.4) <0.0001
Hypertension 2,789 (24.4) 1,540 (30.0) 785 (21.7) 464 (17.4) <0.0001
Current smoker 1,652 (14.5) 1,035 (20.2) 428 (11.8) 189 (7.1) <0.0001
Heavy drinker 762 (6.7) 321 (6.3) 239 (6.6) 202 (7.6) 0.0319
Physical inactivity 2,226 (19.5) 1,764 (34.4) 374 (10.3) 88 (3.3) <0.0001
Parental history of CVD 3,034 (26.6) 1,423 (27.7) 933 (25.7) 678 (25.5) 0.0175
Values are mean  SD or n (%). Linear trend for TG and TG/HDL-C ratio was tested after log-transformation due to excessive skewness. CRF was categorized into low (lower
than 33.3th percentile), middle (those within 33.3th to 66.7th percentile) and high CRF categories (higher than 66.7th percentile) according to the distribution of age-
standardized CRF at baseline.
BMI ¼ body mass index; CRF ¼ cardiorespiratory ﬁtness; CVD ¼ cardiovascular disease; HDL-C ¼ high-density lipoprotein cholesterol; LDL-C ¼ low-density lipoprotein
cholesterol; METs ¼ metabolic equivalent(s); TC ¼ total cholesterol; TG ¼ triglycerides.
TABLE 2 Distributio
Overa
(N ¼ 11,4
Number of
visits
3.8  2
Follow-up
time, yrs
5.9  5
Values are mean  SD.
Park et al. J A C C V O L . 6 5 , N O . 1 9 , 2 0 1 5
Trajectories of Lipids and Lipoproteins With Aging M A Y 1 9 , 2 0 1 5 : 2 0 9 1 – 1 0 0
2094ratio, TC/HDL-C ratio, and LDL-C/HDL-C ratio, and
was positively associated with HDL-C. The lower
CRF category had higher BMI, WC, % BF, FPG, and
systolic and diastolic BP and had increased preva-
lence of diabetes, hypertension, current smoking,
physical inactivity, and parental history of CVD.
Table 2 presents the number of participants, number of
visits, and follow-up time by age group. Compared
with younger individuals, older individuals tended to
have longer follow-up durations (p < 0.0001).n of Number of Visits and Follow-Up Time by Age Group
ll
18)
Age group, yrs
p Value for
Linear Trend
20–39
(n ¼ 1,711)
40–49
(n ¼ 4,077)
50–59
(n ¼ 3,680)
$60
(n ¼ 1,950)
.8 2.6  1.0 3.1  1.7 4.1  2.8 6.0  4.3 <0.0001
.4 3.1  2.7 4.6  3.9 6.6  5.4 9.9  6.9 <0.0001MARGINAL MODELS FOR LONGITUDINAL CHANGE
IN LIPIDS AND LIPOPROTEINS WITH AGING. Model 1
was deﬁned as the age-related trajectories of TC,
LDL-C, log TG, HDL-C, and non–HDL-C (Table 3). The
age-squared term was signiﬁcant for all lipids and li-
poproteins, indicating that longitudinal aging trajec-
tories for lipids and lipoproteins are consistently
nonlinear. Age-squared was inversely associated with
TC, LDL-C, log TG, and non–HDL-C (all p < 0.0001)
and showed a positive relation to HDL-C (p ¼ 0.002).
In other words, TC, LDL-C, log TG, and non–HDL-C
have inverted U-shaped quadratic trends with aging,
meaning that they all tend to increase up to a certain
age and then subsequently decrease. In contrast,
HDL-C has a U-shaped quadratic trend with aging.
When CRF and an interaction term of age–CRF were
added to model 2, the model ﬁts were improved
on the basis of each lipid and lipoprotein’s Akaike
information criterion and Bayesian information cri-
terion values. In model 2, CRF was inversely asso-
ciated with TC, LDL-C, TG, and non–HDL-C (all
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2095p < 0.0001) and was positively associated with HDL-C
(p < 0.0001). The age–CRF interaction was signiﬁcant
(all p < 0.01), indicating that the associations of CRF
with lipids and lipoproteins are not consistent across
different ages.
In Table 4, TC, LDL-C, log TG, and non–HDL-C
showed persistently inverse associations with age-
squared (all p < 0.0001), whereas the signiﬁcant
association with age-squared in HDL-C disappeared
after adjusting for all time-varying covariates such as
WC, % BF, FPG, systolic and diastolic BP, smoking
status, alcohol drinking status, and physical activity
habit. CRF also consistently exhibited an inverse
association with TC, LDL-C, TG, and non–HDL-C (all
p < 0.0001) and a positive association with HDL-C
(p <0.0001). The age–CRF interaction was also sig-
niﬁcant (all p < 0.01).
GRAPHICAL TRAJECTORIES FOR LIPIDS AND LIPO-
PROTEINS WITH AGING. Central Illustration and
Figure 2 show the estimated trajectories of lipids and
lipoproteins with aging and the corresponding 95%
conﬁdence bands on the basis of baseline CRF level.
When the WC residual was added to model 2, the
estimates of age-squared changed by over 10% in TG,
HDL-C, and non–HDL-C, and the signiﬁcant associa-
tion with age-squared in HDL-C disappeared (Online
Table 1). TC and TG tended to increase with age un-
til the age of early 50s, whereas LDL-C and non–HDL-
C tended to increase with age until around the age of
late 40s, after which decreased trends were observed.
In contrast, HDL-C tended to increase slightly over all
age periods. All 3 lipid and lipoprotein ratio variables,
including TG/HDL-C, TC/HDL-C, and LDL-C/HDL-C,
tended to increase with age until the age of early to
mid-40s, with decreased trends observed after the
40s.
In these trajectories, men with low CRF showed a
higher risk of developing abnormal lipid and lipo-
protein proﬁles around the age of mid-20s through
the late 30s. Notably, abnormal values for TC and
LDL-C in men with low CRF were observed around 15
years earlier than in those with high CRF. For non–
HDL-C and TG/HDL-C ratio, no period for abnormal
values was observed in those with high CRF. The
trajectories of the TC/HDL-C and LDL-C/HDL-C ratios
were similar to those of the TG/HDL-C ratio.
SENSITIVITY ANALYSES. When data were analyzed
from subjects with no abnormal lipid proﬁles, dia-
betes mellitus, or hypertension at baseline, and no
known diabetes mellitus or hypertension at follow-up
examinations, the overall results are not very
different from those of the original dataset. After
adjusting for all covariates, TC, LDL-C, TG, and
TABLE 4 Population-Averaged Coefﬁcients and Standard Errors for All Predictors for Lipids and Lipoproteins From Generalized Estimating Equation Models
TC LDL-C Log TG HDL-C Non–HDL-C
b SE b SE b SE b SE b SE
Intercept 171.6* 2.4 119.8* 2.1 4.12* 0.04 41.40* 0.70 130.1* 2.3
Age 0.082‡ 0.027 0.232* 0.025 0.00083§ 0.00042 0.2085* 0.0087 0.298* 0.028
Age2 0.039* 0.002 0.032* 0.002 0.00026* 0.00003 0.00001 0.00051 0.039* 0.002
Baseline examination
date
0.907* 0.038 1.026* 0.034 0.00070 0.00060 0.1298* 0.0137 1.036* 0.038
CRF 2.024* 0.106 1.961* 0.097 0.07237* 0.00181 1.4381* 0.0340 3.521* 0.105
Age  CRF 0.068* 0.010 0.038* 0.009 0.00067* 0.00016 0.0200* 0.0031 0.047* 0.010
Waist circumference 0.250* 0.030 0.211* 0.027 0.00914* 0.00065 0.1648* 0.0114 0.428* 0.034
Percent body fat 0.613* 0.045 0.582* 0.042 0.00623* 0.00083 0.1156* 0.0153 0.729* 0.046
Fasting glucose 0.086* 0.016 0.024 0.013 0.00289* 0.00025 0.0042 0.0044 0.083* 0.015
Diastolic BP 0.218* 0.020 0.134* 0.018 0.00248* 0.00035 0.0334* 0.0060 0.184* 0.019
Systolic BP 0.061* 0.015 0.005 0.014 0.00114* 0.00026 0.0322* 0.0047 0.030§ 0.015
Current smoker 0.932 0.555 0.594 0.509 0.03612† 0.00996 0.5015‡ 0.1747 1.319§ 0.552
Heavy drinker 4.160* 0.696 0.292 0.626 0.00596 0.01015 3.1648* 0.2277 0.650 0.685
Physical inactivity 1.999* 0.378 1.314† 0.347 0.00687 0.00707 0.5160* 0.1078 1.509* 0.370
Waist circumference and percent body fat were normalized by CRF. *p < 0.0001. †p < 0.001. ‡p < 0.01. §p < 0.05.
BP ¼ blood pressure; other abbreviations as in Table 1.
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2096non–HDL-C showed consistently inverse associations
with age-squared (all p < 0.0001), indicating inverted
U-shaped quadratic trends with aging. There were
signiﬁcant inverse associations of CRF with TC,
LDL-C, TG, and non HDL-C, and there was a positive
association with HDL-C (all p < 0.0001) (Online
Table 2). Similar results were found in the subgroup
analysis for subjects with low-fat or -cholesterol di-
etary habits (Online Table 3).
DISCUSSION
Our ﬁndings from a prospective study of 11,418 men
support that CRF is associated inversely with TC, LDL-
C, TG, and non–HDL-C and is associated positively
with HDL-C. Men with higher CRF had more favorable
lipid proﬁles than those with lower CRF from the age
of early 20s until the age of early 60s or mid-70s. In
addition, the trajectories of TC, LDL-C, TG, and non–
HDL-C had inverted U-shaped quadratic relationships
with aging. There was a signiﬁcant interaction be-
tween age and CRF in each trajectory, with CRF
inﬂuencing the aging trajectories of lipids and lipo-
proteins mainly in young to middle-age men, but with
little effect on the elderly. Furthermore, men with
lower CRF levels reached abnormal TC ($200 mg/dl),
LDL-C ($130 mg/dl), non–HDL-C ($160 mg/dl), and
TG/HDL-C ratio ($3) before 40 years of age, notably
earlier than in those with higher CRF levels.
Overall trends of lipids and lipoproteins with aging
over the adult lifespan were generally consistent with
the results of previous studies (9,10,12,13). It is likely
that multiple lifestyle factors may be involved inthese age-related lipid changes, including changes in
BF distribution (13). Overall BF tends to increase,
especially in the abdominal region, which causes in-
sulin resistance, the potential mechanism underlying
dyslipidemia. Under conditions of abdominal obesity,
free fatty acids (FFAs) are released abundantly from
enlarged adipose tissue. The increased ﬂux of FFAs
from the blood to the liver promotes hepatic TG
synthesis, overproduction of TG containing very low-
density lipoprotein, and increased apolipoprotein B
in the liver (32). This altered lipid metabolism con-
tributes to the insulin resistance that leads to
elevated FFA levels (33).
Several epidemiological studies have shown that TC,
LDL-C, and TG decrease after middle age (11,13–15).
Decreased cholesterol concentrations with advancing age
couldbeexplainedby the relationshipof the inﬂammatory
response to common chronic diseases (16), reduction of
cholesterol absorption due to metabolic and hormonal
changes with aging (34), and poor health status (13).
However, these effects may be minimized in the present
study because subjects with a history of myocardial
infarction, stroke, and cancer were excluded. In addition,
the results of sensitivity analysis after excluding subjects
with diabetes or hypertension were consistent with our
main ﬁnding. It is also possible that those who live longer
have a more favorable lipid proﬁle in terms of selective
survival.
Previous studies demonstrated that HDL-C
decreased (13–15) or did not change with advancing
age (12,16). However, HDL-C tended to increase with
age when mean HDL-C was compared among repre-
sentative U.S. men with almost 10-year differences
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2097between the survey periods, supposing that those in
the same age group were the same cohort (e.g., mean
HDL-C of men age 40 to 49 years in the 1988 to 1994
survey vs. that of men age 50 to 59 years in the 1999
to 2002 survey) (9,11). The present study also showed
the trend of increasing HDL-C with age. In addition,
despite a signiﬁcant interaction of age–CRF, the
graphical illustration of HDL-C trajectories with age
are not so prominent, perhaps due to the generally
small variation of HDL-C with age (9,11). Thus, a
future study using a population with a wider range of
HDL-C is warranted to more clearly discern the pro-
tective effect of CRF on the age-related HDL-C
trajectory.
The distribution of TG in the age-TG trajectory
(Figure 2B) was relatively low compared with that of
other lipids and lipoproteins in the trajectories of TC
(Central Illustration), LDL-C (Figure 2A), and non–HDL-C
(Figure 2D), using suggested cutoffs for elevated CHD
risk (3,31). In addition, TG concentrations at baseline
were around 10 to 20 mg/dl lower than those from
national data over a similar period (11), possibly due to
the characteristics of this study’s healthy population.
Although the trajectories for HDL-C were below the 60
mg/dl cutoff for high HDL-C over most of the lifespan
(Figure 2C), they were not signiﬁcantly different from the
HDL-C distribution in the national survey (11). However,
the age-related trajectory for the composite variable of
TG/HDL-C ratio, which is a surrogate marker for insulin
resistance and a CHD risk factor (30), showed a pattern
similar to those of TC, LDL-C, and non–HDL-C, in which
men with lower CRF reached the abnormal cutoff values
considerably earlier. The TC/HDL-C and LDL-C/HDL-C
ratios, both of which are generally considered better
predictors of CHD risk than a single proﬁle of lipids and
lipoproteins (35), showed a similar age-related trajectory
pattern to the TG/HDL-C ratio when cutoffs for abnormal
levels were set at $4.5 for the TC/HDL-C ratio and $3.0
for the LDL-C/HDL-C ratio (36,37).
Prior studies indicate that CRF is independently
and inversely associated with dyslipidemia (18,19),
whereas CRF improves lipid and lipoprotein proﬁles
through mechanisms that increase lipoprotein lipase
activity in skeletal muscle, resulting in an increased
TG clearance rate, improved HDL-C, and enhanced
transport of lipids and lipoproteins from the periph-
eral circulation and tissues to the liver (19,38). The
effect of physical activity and exercise on improving
lipid and lipoprotein proﬁles may differ for different
age groups (39). A signiﬁcant interaction between age
and CRF was found in the present study, in which
CRF inﬂuenced the aging trajectories of lipids
and lipoproteins mainly among young to middle-
age men, but had little effect on the elderly.Speciﬁcally, CRF was consistently a protective factor
for abnormal lipid and lipoprotein proﬁles, and this
prominent effect most frequently appeared between
the age of early 20s and early 60s for TC, LDL-C, and
non–HDL-C, and between the age of early 20s and
early 70s for TG and HDL-C. Our ﬁndings showed that
abnormal LDL-C began to occur at around 30 years of
age in men with low CRF levels and around the age of
mid-40s in men with high CRF levels. Abnormal TC
levels also began to occur at the age of early 30s in
men with low CRF levels, but were delayed until the
age of mid-40s in men with high CRF levels.
Furthermore, men with low CRF levels reached
abnormal TG/HDL-C ratios and non–HDL-C levels
around the age of early 20s and mid-30s, respec-
tively, but men with high CRF levels kept their values
for TG/HDL-C ratio and non–HDL-C below the
abnormal cutoffs over the entire lifespan. These
ﬁndings indicate that men with higher CRF are more
likely to reach abnormal values for lipids and lipo-
proteins at least a decade later than men in the low
CRF category. This suggests that improving CRF
levels may delay the period of elevated serum lipids
FIGURE 2 The Estimated Trajectories of Lipids and Lipoproteins With Aging by Levels of CRF
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2098and lipoproteins. These data are especially clinically
relevant for LDL-C, because the recent American
College of Cardiology/American Heart Association
guideline shows that aerobic physical activity re-
duces LDL-C by an average of 3.0 to 6.0 mg/dl (17). In
addition, although the treatment targets for LDL-C
and non–HDL-C are abandoned by some clinicians,
but not all (40), LDL-C and non–HDL-C still playimportant roles in deﬁning the risk group for pre-
vention of atherosclerotic CVD (41).
STUDY STRENGTHS AND LIMITATIONS. Strengths of
our study include its prospective study design,
permitting longitudinal measures of lipids, lipopro-
teins, and time-varying covariates for assessing tra-
jectories with aging. Using a relatively large sample
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: CRF is more
strongly associated with the aging trajectories of lipids and li-
poproteins in young and middle-age men than in older men, and
promoting CRF can delay the development of dyslipidemia.
TRANSLATIONAL OUTLOOK: Additional research is needed
to determine whether CRF could change the age-related trajec-
tories of lipids and lipoproteins in patients taking lipid-lowering
medications.
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2099size over the entire lifespan, stable estimates were
obtained in the main analysis and in sensitivity ana-
lyses. However, our study has limitations. First, loss
to follow-up may affect the validity of the study re-
sults, although this is not a substantial issue in the
ACLS (42). The present study includes relatively
healthy men who primarily were white and from
middle to upper socioeconomic status, which might
reduce the generalizability of the results, but also
potentially minimizes residual confounding by so-
cioeconomic status. Second, there was no informa-
tion on lipid-lowering medication. Thus, we excluded
those who reported a history of high cholesterol or
high TG at baseline and at each follow-up visit to
minimize the likely effect of lipid-lowering medica-
tion on lipids and lipoprotein trajectories. Also, a
sensitivity analysis was performed to determine
whether the presence of metabolic abnormalities
would potentially affect the consistency of the results
at baseline and follow-up. Third, due to small sample
size, 95% conﬁdence intervals in each trajectory
tended to be wider in older individuals, which may
render the estimates of trajectories less precise.
Finally, longitudinal changes in lipids and lipopro-
teins may be affected by dietary habit changes (16)
that were not included in the models. However,
analysis of the subgroup with records of low-fat or
low-cholesterol diets indicated there was little dif-
ference in the data (Online Table 3).
CONCLUSIONS
TC, LDL-C, TG, and non–HDL-C gradually increase
until the age of mid-40s to early 50s, with subsequentdeclines thereafter; in contrast, HDL-C increases
steadily with aging in healthy men. Independent
of time, varying lifestyle, and metabolic characteris-
tics, a higher CRF has a signiﬁcant contribution to
maintaining favorable lipid and lipoprotein proﬁles,
especially in young to middle-age men. Therefore,
promoting CRF may contribute to a possible de-
lay of dyslipidemia and its related atherosclerosis
and CVD.
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